Literature DB >> 6104919

Pulmonary function in patients with inflammatory bowel disease.

O E Eade, C L Smith, J R Alexander, P J Whorwell.   

Abstract

Pulmonary function has been assessed in 36 outpatients with inflammatory bowel disease. The carbon monoxide transfer factor was found to be significantly reduced in patients as compared with matched controls (P less than 0.01). The reason for this reduction is not clear but it is unlikely to be due to sulfasalazine (Salazosulphapyridine).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6104919

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  17 in total

1.  Crohn's disease of the lung.

Authors:  J W Puntis; M J Tarlow; F Raafat; I W Booth
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

2.  Inflammatory bowel disease and the lung: is there a link between surgery and bronchiectasis?

Authors:  Michael G Kelly; Frank A Frizelle; Peter T Thornley; Lutz Beckert; Michael Epton; A Craig Lynch
Journal:  Int J Colorectal Dis       Date:  2006-04-20       Impact factor: 2.571

3.  Organizing pneumonia: a rare pulmonary manifestation of well-controlled ulcerative colitis.

Authors:  Xiaoming Zhou; Yu Chen; Li Zhao
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

4.  Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies.

Authors:  P Bonniere; B Wallaert; A Cortot; X Marchandise; Y Riou; A B Tonnel; J F Colombel; C Voisin; J C Paris
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

Review 5.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Xiao-Qing Ji; Li-Xia Wang; De-Gan Lu
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 6.  [Bronchopulmonary manifestations of gastroenterologic and hepatic diseases].

Authors:  A Tromm; G H Micklefield; D Hüppe
Journal:  Med Klin (Munich)       Date:  1997-12-15

Review 7.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

8.  Sulfasalazine-induced pulmonary disease.

Authors:  R H Moseley; K W Barwick; K Dobuler; V A DeLuca
Journal:  Dig Dis Sci       Date:  1985-09       Impact factor: 3.199

9.  Ulcerative colitis and sarcoidosis.

Authors:  G D Barr; D J Shale; D P Jewell
Journal:  Postgrad Med J       Date:  1986-05       Impact factor: 2.401

Review 10.  Pulmonary involvement and allergic disorders in inflammatory bowel disease.

Authors:  Nikolaos E Tzanakis; Ioanna G Tsiligianni; Nikolaos M Siafakas
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.